New York – November 05, 2026 -- The Vaccine Guidance Review Panel, a multi-society effort of four U.S. medical organizations, has endorsed influenza, RSV and COVID-19 vaccination recommendations for adults and children. The guidance is aligned with Advisory Committee on Immunization Practices (ACIP) recommendations issued before June 2025.
Panel draws on four specialty societies and four guidance issuers
Experts from the American Academy of Allergy, Asthma & Immunology (AAAAI), the American Thoracic Society (ATS), the American College of Chest Physicians (CHEST) and the Society of Critical Care Medicine (SCCM) reviewed the vaccination-development process. They unanimously endorsed it, together with the resulting guidance from the American Academy of Pediatrics (AAP), the American Academy of Family Physicians (AAFP), the American College of Obstetricians and Gynecologists (ACOG) and the Infectious Diseases Society of America (IDSA).
Panel offers a single reference amid a stay on HHS and ACIP decisions
The panel is intended as one up-to-date reference for clinicians focused on respiratory health. It arrives during a transition in national immunization advisory processes, following a temporary stay on multiple vaccine decisions made by HHS and ACIP dating back to May 2025.
The societies say 2025 changes in CDC and ACIP processes produced potentially harmful updates to the vaccine schedule. They cite this as the reason for collaborating, including to ensure COVID-19 vaccine recommendations align with those of AAP, ACOG, AAFP and IDSA.
Society presidents stress clarity ahead of respiratory virus season
ATS President Michelle Ng Gong said clinicians and patients with serious lung disease "should not have to navigate a labyrinth of confusion" as the respiratory virus season approaches.
CHEST President Neil Freedman said the partnership aims to provide education and protect equitable access to preventative medicine and care. SCCM President Cherylee W. J. Chang called vaccination one of the most effective tools to prevent severe disease. AAAAI President Carla Davis said the recommendations reflect scientific evidence and clinical expertise.
Combined membership exceeds 62,000 across the four societies
AAAAI counts more than 7,100 members, ATS more than 22,000, CHEST more than 18,000 and SCCM more than 15,000 in over 100 countries.